Compare BWMN & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BWMN | RZLT |
|---|---|---|
| Founded | 1995 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 508.6M | 420.8M |
| IPO Year | 2021 | 2011 |
| Metric | BWMN | RZLT |
|---|---|---|
| Price | $26.10 | $5.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $45.50 | $9.67 |
| AVG Volume (30 Days) | 129.2K | ★ 1.7M |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 329.41 | 26.32 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $490,017,000.00 | N/A |
| Revenue This Year | $14.93 | N/A |
| Revenue Next Year | $11.57 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 14.88 | N/A |
| 52 Week Low | $25.07 | $1.07 |
| 52 Week High | $45.83 | $11.46 |
| Indicator | BWMN | RZLT |
|---|---|---|
| Relative Strength Index (RSI) | 31.75 | 54.10 |
| Support Level | $25.52 | $2.91 |
| Resistance Level | $36.86 | $5.42 |
| Average True Range (ATR) | 1.12 | 0.35 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 20.81 | 63.35 |
Bowman Consulting Group Ltd is a professional services firm delivering engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, geospatial, survey, land procurement, and other technical services to customers operating in a diverse set of end markets. Its services include Civil & Site Engineering, Transportation Engineering, MEP Engineering, Commissioning & Energy Efficiency, Energy Services, Water/Wastewater, Fire Protection, Construction Management, Survey/Geospatial, Environmental Consulting, Structural Engineering, Land Procurement & Right-of-Way, Landscape and Architecture/Planning.
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.